Shire Pharmaceuticals Inc Wayne, PA - 19087

Shire Pharmaceuticals Inc is categorized under Analytical Instruments in Wayne, PA and active since 2005.

Shire Pharmaceuticals Inc was established in 2005, and today employs 1 to 4, earning $100.000.000 to $499.999.999 per year. This is a Analytical Instruments business, which does work in the B2B market, and is classified as a Analytical Instruments, under code number 334516 by the NAICS.

If you are seeking more information, feel free to contact Matthew Emmens at the company’s headquarters by writing to 725 Chesterbrook Boulevard, Wayne, Pennsylvania PA 19087 or by phoning (484) 595-8800. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Shire Pharmaceuticals Inc
Contact Person: Matthew Emmens
Address: 725 Chesterbrook Boulevard, Wayne, Pennsylvania 19087
Phone Number: (484) 595-8800
Website Address: shire.com
Annual Revenue (USD): $100.000.000 to $499.999.999
Founded: 2005
Location Type: Headquarters
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Analytical Instruments
SIC Code: 3826
NAICS Code: 334516
Share This Business:

Shire Pharmaceuticals Inc was started in 2005 to provide professional Analytical Instruments under the SIC code 3826 and NAICS code 334516. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000.000 to $499.999.999 per annum.

Feel free to contact Matthew Emmens for inquiries that concern Shire Pharmaceuticals Inc by calling the company number (484) 595-8800, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Shire Pharmaceuticals Inc can be found at the coordinates 40.070359,-75.459678 as well as the street address 725 Chesterbrook Boulevard in Wayne, Pennsylvania 19087.

For its online presence, you may visit Shire Pharmaceuticals Inc’s website at shire.com and engage with its social media outlets through on Twitter and on Facebook.